Morbidity and Mortality in Young-Onset Type 2 Diabetes in Comparison to Type 1 Diabetes: Where Are We Now?
- 910 Downloads
Increasingly, we recognise that type 2 diabetes in youth is a disease with an aggressive time course and a significant complication risk. On the other hand, outcomes for youth with type 1 diabetes appear generally to be improving. With increasing numbers of both types of diabetes in youth, it is timely that a comparative perspective is offered to help clinicians prognosticate more appropriately. Contemporary comparative studies add a new perspective to a consistent story, that for youth-onset type 2 diabetes, the development and progression of cardio-renal complications are increased and the survival prognosis is significantly worse than for type 1 diabetes. Here, we review this mounting evidence, highlight the importance of metabolic syndrome factors in the excess risk and underscore that there remains a significant mortality gap for youth with either type of diabetes, to be addressed as a matter of urgency.
KeywordsDiabetes mellitus Type 1 diabetes Type 2 diabetes Youth Mortality Diabetes complications
Compliance with Ethics Guidelines
Conflict of Interest
Jencia Wong, Maria Constantino and Dennis Yue declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•Imperatore GMDP, Boyle JPPHD, Thompson TJMS, Case DPHD, Dabelea DMD, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12):2515–20. This study provides estimates of the future burden of disease in the context of increaing numbers of youth with type 1 and type 2 diabetes.Google Scholar
- 8.••TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247–56. The TODAY trial is the first RCT examining diabetes management in YT2DM. Publications arising from this trial highlight the severe phenotype in YT2DM, the progressive beta cell decline and progression of risk factors for this patient group.Google Scholar
- 15.•Luk AO, Lau ES, So WY, Ma RC, Kong AP, Ozaki R, et al. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes. Diabetes Care. 2014;37(1):149–57. YT2DM is a growing problem in Asia and this large study is one of few that examines diabetes complications specifically in Chinese with obese and non obese YT2DM, in comparison to T1DM.Google Scholar
- 24.•Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care. 2012;35(6):1265–71. This large study examines the burden of kidney disease and end-stage renal disease using prospectively collected data in YT2DM and type 1 diabetes.Google Scholar
- 28.•Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863–9. This study utilises a long-term diabetes database to examine the long-term mortality differences in type 1 and type 2 diabetes of equivalent age of onset.Google Scholar
- 38.Jaiswal M, Lauer A, Martin CL, Bell RA, Divers J, Dabelea D, et al. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Diabetes Care. 2013;36(12):3903–8.PubMedCentralPubMedCrossRefGoogle Scholar
- 45.Alman AC, Talton JW, Wadwa RP, Urbina EM, Dolan LM, Daniels SR, et al. Cardiovascular health in adolescents with type 1 diabetes: The SEARCH CVD Study. Pediatr Diabetes. 2014;15(7):502–10. doi: 10.1111/pedi.12120.
- 48.Prevention CfDca. FastStats—deaths and mortality.Google Scholar
- 51.•Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes. 2012;61(11):2987–92. The Pittsburgh EDC study is an important population study which provides new evidence for improving outcomes in T1DM.Google Scholar
- 58.Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2010;53(11):2312–9.PubMedCentralPubMedCrossRefGoogle Scholar
- 65.Dyck RF, Jiang Y, Osgood ND. The long-term risks of end stage renal disease and mortality among First Nations and non-First Nations people with youth-onset diabetes. Can J Diabetes. 2014;38(4):237–43. doi: 10.1016/j.jcjd.2014.03.005.